Which hedge funds own DSGN? DESIGN THERAPEUTICS INC, Q2 2026 13F holders
Healthcare · Open on the interactive board
6 of the hedge funds tracked by WhaleCreep disclosed a position in DSGN (DESIGN THERAPEUTICS INC) in their Q2 2026 13F filings, worth $56.1m in total. The largest holder by portfolio weight is Point72 Asset Management LP at 0.1% of its book. 3 exited: Brevan Howard Capital Management, Marshall Wace, RA Capital Management.
6tracked managers holding
0opened this quarter
3exited this quarter
Which hedge funds hold DSGN? Current holders by portfolio weight
| Manager | As of | Weight of book | Value | Shares | Δ shares | Action |
|---|---|---|---|---|---|---|
| Point72 Asset Management LP | Q2 2026 | 0.1% | $34.2m | 2,366,453 | -13% | reduced |
| Woodline Partners | Q2 2026 | 0.0% | $10.1m | 700,354 | -27% | reduced |
| Renaissance Technologies LLC | Q2 2026 | 0.0% | $5.6m | 387,913 | -5% | reduced |
| D. E. Shaw & Co | Q2 2026 | 0.0% | $2.8m | 195,645 | -58% | reduced |
| Millennium Management | Q2 2026 | 0.0% | $2.1m | 147,714 | 36% | added |
| Citadel Advisors | Q2 2026 | 0.0% | $1.2m | 81,971 | -65% | reduced |
Exited since the previous quarter
| Manager | Prior weight | Prior value |
|---|---|---|
| Brevan Howard Capital Management | 0.0% | $162.7k |
| Marshall Wace | 0.0% | $1.6m |
| RA Capital Management | 1.0% | $31.6m |
How has hedge fund ownership of DSGN changed?
| Quarter | Managers holding | Combined value |
|---|---|---|
| Q2 2026 | 6 | $56.1m |
| Q1 2026 | 9 | $85.6m |
| Q4 2025 | 4 | $75.6m |
| Q3 2025 | 4 | $35.4m |
| Q2 2025 | 3 | $9.6m |
| Q1 2025 | 3 | $10.5m |
| Q4 2024 | 2 | $13.0m |
| Q3 2024 | 3 | $10.2m |
| Q2 2024 | 3 | $4.7m |
| Q1 2024 | 3 | $4.3m |
| Q4 2023 | 1 | $1.7m |
| Q3 2023 | 3 | $426.5k |
| Q2 2023 | 4 | $19.5m |
| Q1 2023 | 4 | $17.9m |
| Q4 2022 | 2 | $30.7m |
| Q3 2022 | 2 | $46.8m |
Counts every tracked manager that disclosed DSGN in that quarter's filing, including managers that have since stopped filing.